A clinical trial involving individuals genetically predisposed to develop early-onset Alzheimer’s disease suggests that removing amyloid from the brain may help prevent symptoms, highlighting the need for further confirmatory studies. An…
Breakthrough Drug Cuts Alzheimer’s Risk by 50% in High-Risk Patients
